3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Kimberly-Clark extended the expiration date of its offers to exchange up to $7.0 billion of Kenvue notes for new Kimberly-Clark notes, from October 27 to November 2, 2026. The exchange offers are conditioned on completing its pending acquisition of Kenvue, which the company cannot waive, so the extension keeps the financing step tied to that deal on schedule.
Expiration date moved from 5:00 p.m. New York time on October 27, 2026 to 5:00 p.m. on November 2, 2026, and may be extended further.
Tendered amounts as of October 27, 2026 ranged from 73.93% to 98.54% of outstanding principal across seven note series.
Amendments to the Kenvue indenture were approved on October 9, 2026 and take effect only when the exchange offers settle.
The offers are conditioned on completion of the Kenvue acquisition, a condition Kimberly-Clark may not waive.
Sands China Ltd., Las Vegas Sands' majority-owned subsidiary, priced $700 million of 6.400% senior notes due 2032 and $300 million of 6.700% senior notes due 2033, with closing expected November 3, 2026. The company plans to use net proceeds of about $989 million, together with cash on hand, to redeem its $700 million 2.300% notes due 2027 and repay its 2024 SCL Revolving Facility balance, which refinances existing debt and adds new long-term borrowing at the subsidiary level.
Priced $700 million of 6.400% senior notes due 2032 and $300 million of 6.700% senior notes due 2033
Offering expected to close on November 3, 2026, subject to customary closing conditions
Net proceeds of approximately $989 million plus cash on hand to redeem $700 million 2.300% notes due 2027 and repay the 2024 SCL Revolving Facility balance
Notes are unregistered and offered only to professional and qualified institutional investors; Sands China proposes a Hong Kong Stock Exchange listing
Bread Financial Holdings priced an underwritten public offering of 5,000,000 depositary shares, each representing a 1/40th interest in its 9.375% Series C fixed rate reset non-cumulative perpetual preferred stock. The company expects approximately $120,162,500 in net proceeds, assuming no exercise of the underwriters' option, for general corporate purposes that may include contributing or lending funds to its subsidiary bank, Comenity Capital Bank, and share repurchases. Shareholders will see new preferred securities outstanding once the offering closes, expected November 3, 2026.
5,000,000 depositary shares priced, each with a $25 liquidation preference (equivalent to $1,000 per Series C preferred share)
Underwriters have a 30-day option to buy up to an additional 750,000 depositary shares at the same price
Expected net proceeds of approximately $120,162,500 without option exercise; closing expected November 3, 2026
Proceeds may fund general corporate purposes, including contributions or loans to Comenity Capital Bank and share repurchases
On October 27, 2026, Aclaris Therapeutics entered an underwriting agreement to sell 7,785,714 shares of common stock at $3.50 each, plus pre-funded warrants for 6,500,000 shares, in an offering under an effective Form S-3 registration. The Company estimates net proceeds of about $46.7 million, with closing expected on October 28, 2026. Because the offering adds new shares and warrants, existing shareholders' ownership percentage could be diluted.
7,785,714 common shares offered at $3.50 per share
Pre-funded warrants for 6,500,000 shares priced at $3.49999 each, with a $0.00001 exercise price
Estimated net proceeds of about $46.7 million; closing expected October 28, 2026
Underwriters include Leerink Partners LLC, Piper Sandler & Co. and Cantor Fitzgerald & Co.
Hydrofarm sold about 8.6 million common shares and pre-funded warrants at $0.905 per share in a registered direct and private placement, with gross proceeds of $8.3 million before fees and expenses. Investors also received common warrants for up to 9,210,975 shares at $0.78, which dilutes existing holders and adds potential future share issuance. The filing also describes side letter and registration terms with lenders tied to a restructuring, including rights to designate board members subject to stockholder approval.
Registered direct offering of 1,599,400 shares at $0.905 per share, plus a concurrent private placement of 6,971,575 shares and pre-funded warrants for 640,000 shares, all closed October 27, 2026.
Common warrants for up to 9,210,975 shares at $0.78 per share expire 5.5 years after issue; the placement agent, ThinkEquity LLC, receives a cash fee of 8% of the purchase price.
Under a side letter with lenders, the lenders may designate 1 initial director and up to 3 additional directors, subject to stockholder approval under Nasdaq Rule 5635.
The company must file a resale registration statement by the 15th calendar day after the registration rights agreement date, or pay partial liquidated damages of 2.0% of the subscription amount for each affected holder.
Blackstone's indirect subsidiary, Blackstone Reg Finance Co. L.L.C., priced an underwritten public offering of $1.1 billion in senior notes, with the notes fully guaranteed by Blackstone and five related Blackstone Holdings partnerships. Blackstone said it intends to use the net proceeds for general corporate purposes, and the filing does not describe any change in operating results or guidance.
$600 million of 5.650% senior notes due 2031 priced
$500 million of 5.900% senior notes due 2033 priced
Notes offered under a shelf registration statement filed December 2, 2024, as amended February 27, 2026
Net proceeds to be used for general corporate purposes
Watsco entered an unsecured five-year, $750.0 million syndicated multicurrency credit agreement on October 21, 2026, replacing its $600.0 million revolving credit facility from March 2023. The company borrowed $69.7 million at closing to repay the prior facility, and the new facility matures on October 21, 2031. The filing describes the new terms, including pricing, sublimits and financial covenants, but does not state how the company plans to use the added capacity.
New $750.0 million unsecured credit facility dated October 21, 2026, replaces the $600.0 million facility entered into March 16, 2023
$69.7 million borrowed at closing; proceeds used to repay the prior facility, with $69.7 million outstanding as of the closing date
Interest at Term SOFR or Daily Simple SOFR plus 100.0 to 137.5 basis points (100.0 basis points at closing); unused commitment fee 10.0 to 17.5 basis points
Facility matures October 21, 2031; a $150,000 letter of credit from the prior facility remains outstanding and reduces availability
VolitionRx paid $500,000 in cash toward the principal of its $2.4 million senior secured convertible note held by Lind Global Asset Management XII LLC, leaving a balance of $706,667. Under an October 23, 2026 waiver, Lind agreed not to convert the note before January 1, 2027 unless the closing share price reaches $0.275, and the November and December 2026 repayments were deferred. The company says the moves reduce debt and pause conversion rights, which bear on potential share dilution, though the deferrals show the scheduled payments were pushed back.
$500,000 cash prepayment of principal on the note, with $706,667 remaining outstanding
Lind agreed not to exercise conversion rights on or before January 1, 2027, unless the closing price equals or exceeds $0.275 per share
November and December 2026 monthly repayments deferred and kept in outstanding principal
Waiver dated October 23, 2026; company press release issued October 27, 2026
Cricut entered a new five-year, senior secured $300.0 million revolving credit facility led by BMO Bank N.A. as administrative agent, replacing its August 2022 credit agreement with JPMorgan Chase Bank, N.A. The company said no principal was outstanding under the prior facility when it was terminated, and no material early termination penalties were incurred. For shareholders, the filing is primarily a refinancing that adds committed borrowing capacity and permits dividends and share repurchases subject to a leverage test.
New $300.0 million revolving credit facility matures October 22, 2031
Pricing ranges from 1.125% to 2.00% above Adjusted Term SOFR, based on Net Leverage Ratio
Covenants require maximum Net Leverage Ratio of 3.00 to 1.00 and minimum Interest Coverage Ratio of 3.00 to 1.00
Prior credit agreement with JPMorgan Chase Bank, N.A. terminated October 22, 2026 with no principal outstanding
Installed Building Products, Inc. (NYSE: IBP) closed a $250 million increase to its Tranche B-3 term loans on October 27, 2026, under Amendment No. 5 to its credit agreement with Royal Bank of Canada as administrative agent. After the funding, the company says total term loans outstanding are approximately $737.5 million, and the loans mature March 28, 2031. The filing says net proceeds are expected to fund general corporate purposes and associated fees.
$250 million of incremental term loans, funded October 27, 2026, with terms identical to the existing Tranche B-3 Term Loans
Approximately $737.5 million of term loans outstanding after funding, per the 8-K
Interest at adjusted term SOFR plus 1.75% per annum or an alternative base rate plus 0.75%; maturity March 28, 2031
Royal Bank of Canada served as term administrative agent; RBC Capital Markets was lead left arranger and bookrunner
Cayson Acquisition Corp entered an October 23, 2026 agreement with Prisma Global Holding Limited, a Hong Kong advisory firm led by Heming Tan, to help obtain up to $1 million in working capital loans and introduce potential sources of up to $18 million in PIPE financing tied to an eventual business combination. The company also disclosed that its insiders deposited a second monthly extension contribution on October 26, 2026, which extends the deadline to complete a business combination.
Prisma may help obtain working capital loans of up to $1,000,000 before a business combination; the company pays a 10% fee per committed loan, capped at $100,000.
Prisma will introduce potential financing sources of up to $18,000,000 to close alongside a business combination; the fee is to be agreed later.
The company will reimburse Prisma expenses equal to 5% of loans funded, capped at $50,000.
Insiders deposited the second month's $60,000 extension contribution on October 26, 2026; the deadline can extend monthly up to September 23, 2027.
Conexeu Sciences' board approved on October 21, 2026 a warrant inducement program that offers holders of up to 4,762,780 existing warrants at $2.30 per share a new warrant for $0.001 each if they exercise early, before April 30, 2027. The new warrants carry a $3.00 exercise price and a share cap of 2,563,389 shares applies until stockholder approval is obtained under Nasdaq rules on issuances of 20% or more of outstanding shares. Existing shareholders could face additional share issuance, with the total depending on how many holders participate.
Up to 4,762,780 existing warrants at $2.30 per share are eligible for early exercise until 4:00 p.m. Reno time on April 30, 2027.
Each early exercised warrant earns one Inducement Warrant for $0.001, exercisable at $3.00 per share for 24 months from issuance.
Exchange Share Cap of 2,563,389 Inducement Warrant Shares applies until Exchange Cap Stockholder Approval; pre-offering shares outstanding were 29,498,365.
Pooling agreement securities are released 12 months after the May 21, 2026 Nasdaq listing, which is May 21, 2027.
Broadcom said financial partners took on part of certain agreements to buy AI racks built on its custom accelerators, along with related customer leases. The company is providing residual value support to a newly formed special purpose vehicle, with maximum potential liability of approximately $43 billion on an undiscounted basis once the racks are deployed. Shareholders face a large contingent obligation, which the company says it views as having a low probability of occurring.
Arrangement dated October 26, 2026, with financial partners taking on a portion of AI rack purchase agreements and related customer leases
Residual value support provided to a newly formed special purpose vehicle called the Backstop
Maximum potential liability of approximately $43 billion, undiscounted, upon deployment of the AI racks
Potential liability equals the difference between 72.5% of outstanding lease amounts and the value of the racks sold
On October 26, 2026, Hamilton Re and Hamilton Corporate Member Limited entered into an amendment to a letter of credit facility that supports Funds at Lloyd's requirements for Lloyd's Syndicate 4000, with Hamilton Insurance Group as guarantor. The amended unsecured letter of credit is $330 million, expires December 31, 2030, and carries a fee of 150.0 basis points per annum. The filing describes a routine financing arrangement and does not report any change in financial results.
Amended unsecured letter of credit totals $330 million.
Letter of credit expires December 31, 2030.
Facility fee is 150.0 basis points per annum on issued letters of credit.
Lenders include ING Bank N.V., London Branch, Commerzbank AG, New York Branch and Deutsche Bank AG, London Branch.
Endovia Health Sciences entered into an addendum on October 22, 2026, to its equity line of credit with C/M Capital Master Fund, LP, raising the total maximum commitment from $35 million to $135 million, including prior sales. The addendum also sets updated terms for sales made beyond the initial 10,875,000 shares already sold and issued under the agreement, which affects how much new common stock the company may issue over time.
Addendum dated October 22, 2026, amends the Securities Purchase Agreement dated September 19, 2025, with C/M Capital Master Fund, LP
Total maximum commitment increases from $35 million to $135 million, inclusive of prior sales
Updated terms apply to sales above the initial 10,875,000 shares sold and issued under the agreement
Original agreement was filed as Exhibit 10.3 to a Form 8-K on September 25, 2025
Innovative Industrial Properties amended its secured revolving credit facility on October 21, 2026, extending the maturity date from October 23, 2026 to January 21, 2027. The company paid an extension fee, and the filing states that other terms such as commitments, interest rate, borrowing base and covenants are unchanged.
Maturity extended from October 23, 2026 to January 21, 2027 under Amendment Number Six, dated October 21, 2026
$62.5 million in principal was outstanding under the Loan Agreement as of October 21, 2026
IIP OP paid the lenders an extension fee; the filing does not disclose the fee amount
East West Bank is agent; other commitments, interest rate, borrowing base and covenants are not modified
Marsh & McLennan agreed on October 20, 2026 to sell €600 million of 4.250% senior notes due 2032 and €600 million of 4.625% senior notes due 2036 through underwriters, and the notes were issued on October 27, 2026. The filing is a debt financing that adds €1.2 billion of notes to the company's borrowings and does not report any change in earnings or guidance.
€600 million of 4.250% Senior Notes due 2032 and €600 million of 4.625% Senior Notes due 2036 were sold under an October 20, 2026 underwriting agreement
Notes were issued October 27, 2026 under a 2011 indenture with The Bank of New York Mellon as trustee, supplemented by a Twenty-Second Supplemental Indenture
Notes were registered under a Form S-3 shelf filed July 24, 2024
Hydrofarm priced a registered direct offering and concurrent private placement with expected gross proceeds of about $8.3 million, and agreed to satisfy its $109 million senior secured term loan in full by issuing 27.5 million shares of Series 1 Non-Voting Convertible Preferred Stock and warrants for 27.5 million common shares. The conversion and warrant exercise require stockholder approval, and the filing lists dilution to existing stockholders as a risk.
Offering priced at $0.905 per share; expected gross proceeds of about $8.3 million before placement agent fee and expenses, with closing expected on or about October 27, 2026
Term loan of $109 million to be satisfied in full through 27.5 million Series 1 Non-Voting Convertible Preferred Stock shares and Lender Warrants for 27.5 million common shares at $0.78 exercise price
Concurrent private placement includes 9,210,975 Common Warrants exercisable at $0.78 and expiring five and a half years from issuance
Conversion and warrant exercise are subject to shareholder approval; the filing also cites risk of failing to regain Nasdaq continued listing compliance
Blackstone announced that its indirect subsidiary, Blackstone Reg Finance Co. L.L.C., intends to offer senior notes in an underwritten public offering, subject to market and other conditions. The notes will be fully and unconditionally guaranteed by Blackstone Inc. and five of its indirect subsidiaries, and proceeds are intended for general corporate purposes. The filing does not state the offering size, pricing, or interest rate.
Issuer is Blackstone Reg Finance Co. L.L.C., an indirect subsidiary of Blackstone
Notes guaranteed by Blackstone Inc. and Blackstone Holdings I, AI, II, III and IV L.P.
Offering made under a shelf registration filed December 2, 2024, amended February 27, 2026
Proceeds intended for general corporate purposes; underwriters include Citigroup, Goldman Sachs, Morgan Stanley, SMBC Nikko and Wells Fargo
GeoVax entered a revolving loan agreement dated October 25, 2026 with Bowery Consulting Group Inc. for up to $1 million outstanding at one time, at 12% interest, with no amount borrowed as of the filing. The lender can refuse any drawdown at its sole discretion, and either party can terminate the commitment. Five directors resigned effective October 23, 2026, and three lender-designated nominees now make up three of the five board seats, so shareholders should note both the costly, contingent financing and the shift in board control.
Loan facility of up to $1 million at 12% per annum, due on the first anniversary of closing; no amount borrowed as of the filing date
Lender may refuse any drawdown in its sole discretion, and either party may terminate the commitment at any time
Directors Randal Chase, Dean Kollintzas, Nicole Lemerond, Jayne Morgan and John Spencer, Jr. resigned effective October 23, 2026; Steven Brown, Tyler O'Brien and Manpreet Uppal were appointed as lender nominees
Nominees automatically resign if the initial public equity offering is not closed within ten business days after the S-1 becomes effective, or if at least $10 million in total financing is not completed by December 31, 2026
Ellington Credit Company entered an equity distribution agreement on October 23, 2026, allowing it to sell up to $125 million of common shares through four sales agents, at its discretion and with no obligation to sell. Agent commissions are up to 2.0% of gross sales, and proceeds are earmarked for general corporate purposes, including acquiring investments; the sales could dilute existing shareholders, though the filing does not quantify any dilution.
Program size: up to $125,000,000 in aggregate offering price of common shares, with no obligation to sell
Agents: Citizens JMP Securities, B. Riley Securities, Lucid Capital Markets and Armstrong Securities
Agent commissions: up to 2.0% of gross sales price
Shares sold under registration statement declared effective October 21, 2026; proceeds for general corporate purposes
Bread Financial announced the launch of an underwritten public offering of depositary shares, each representing a 1/40th interest in its Series C Non-Cumulative Perpetual Preferred Stock, with a $25 liquidation preference per depositary share. The company intends to use net proceeds for general corporate purposes, which may include contributing or lending funds to its subsidiary bank, Comenity Capital Bank, and share repurchases. The filing does not state the offering size, and completion depends on market and other conditions.
Each depositary share has a $25 liquidation preference, equivalent to $1,000 per Series C preferred share
Proceeds may go to general corporate purposes, including the subsidiary bank Comenity Capital Bank and share repurchases
The company expects to apply to list the depositary shares on the New York Stock Exchange
Morgan Stanley & Co. LLC, Keefe, Bruyette & Woods, RBC Capital Markets, UBS Investment Bank and Wells Fargo Securities are joint bookrunners
Invesco Ltd. borrowed the full $1.5 billion of an unsecured five-year term loan on October 26, 2026, and used it to repurchase $1.5 billion of its 5.9% preference shares held by MassMutual, a significant shareholder owning about 18.5% of common shares. The repurchase was made at a 12.5% premium to the $1,000 liquidation preference, and MassMutual will keep $1 billion of preferred stock. The loan adds debt that carries financial covenants, so it changes the company's debt load and its obligations ahead of common shareholders.
$1.5 billion unsecured term loan dated October 26, 2026, maturing October 26, 2031, borrowed in full at closing and guaranteed by Invesco Ltd.
Proceeds funded repurchase of $1.5 billion of 5.9% Series A Preference Shares from MassMutual at a 12.5% premium to the $1,000 liquidation preference per share.
Loan interest is Term SOFR or a base rate plus a margin; based on current credit ratings, the SOFR margin would be 1.350%.
Quarterly covenants require a Debt/EBITDA ratio of no more than 3.25:1.00 and interest coverage of at least 4.00:1.00.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.